Story thread · 3 reports / 3 sources
Biogen Completes Acquisition of RayThera Inc.
financialpost.com · 4d
Lead program now in Phase 1 development CAMBRIDGE, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing small-molecule therapies in immunology. The acquisition strengthens Biogen’s growing immunology portfolio, adding multiple assets that have […]
First report: Biogen Stock: How To Find & Own America's Greatest Opportunities — investors.com, 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.